Swiss National Bank
NRIX icon

Swiss National Bank’s Nurix Therapeutics NRIX Stock Holding History

Swiss National Bank’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
124,500
-25,500
-17% -$434K ﹤0.01% 1711
2026
Q1 		$2.33M Hold
150,000
– – ﹤0.01% 1772
2025
Q4 		$2.85M Buy
150,000
+16,600
+12% +$238K ﹤0.01% 1689
2025
Q3 		$1.23M Buy
133,400
+2,400
+2% +$24.9K ﹤0.01% 2073
2025
Q2 		$1.49M Buy
131,000
+14,300
+12% +$155K ﹤0.01% 1956
2025
Q1 		$1.39M Buy
116,700
+9,800
+9% +$164K ﹤0.01% 1966
2024
Q4 		$2.01M Hold
106,900
– – ﹤0.01% 1848
2024
Q3 		$2.4M Buy
106,900
+7,700
+8% +$174K ﹤0.01% 1758
2024
Q2 		$2.07M Buy
+99,200
New +$1.54M ﹤0.01% 1794
2023
Q4 		– Sell
-84,800
Closed -$667K – 2584
2023
Q3 		$667K Sell
84,800
-3,100
-4% -$28.3K ﹤0.01% 2432
2023
Q2 		$878K Buy
87,900
+11,600
+15% +$118K ﹤0.01% 2361
2023
Q1 		$678K Sell
76,300
-8,900
-10% -$92.8K ﹤0.01% 2441
2022
Q4 		$935K Buy
85,200
+6,200
+8% +$74.8K ﹤0.01% 2380
2022
Q3 		$1.03M Hold
79,000
– – ﹤0.01% 2320
2022
Q2 		$1M Buy
79,000
+31,500
+66% +$357K ﹤0.01% 2366
2022
Q1 		$665K Buy
47,500
+3,500
+8% +$62.1K ﹤0.01% 2534
2021
Q4 		$1.27M Hold
44,000
– – ﹤0.01% 2328
2021
Q3 		$1.32M Hold
44,000
– – ﹤0.01% 2295
2021
Q2 		$1.17M Buy
44,000
+19,100
+77% +$561K ﹤0.01% 2420
2021
Q1 		$774K Sell
24,900
-200
-0.8% -$7.57K ﹤0.01% 2403
2020
Q4 		$825K Buy
+25,100
New +$832K ﹤0.01% 2369

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swiss National Bank's NRIX Position: Q2 2026 in Review

Swiss National Bank reduced its Nurix Therapeutics (NRIX) stake by 17% in Q2 2026, selling an estimated $434K and leaving 124,500 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Swiss National Bank first reported a position in NRIX in Q4 2020 and has held it in 21 quarters since. 91 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Swiss National Bank held 124,500 shares of Nurix Therapeutics worth $3.02M as of Q2 2026.
  • Swiss National Bank sold 25,500 Nurix Therapeutics shares in Q2 2026, an estimated $434K.
  • Nurix Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1711 holding.
  • Swiss National Bank first reported a position in Nurix Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • 91 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.